Title
Criticism of best practice statement related to sodium-glucose cotransporter-2 inhibitors and serum potassium levels
Recommended Citation
Van Dril L, Schumacher C. Criticism of best practice statement related to sodium-glucose cotransporter-2 inhibitors and serum potassium levels. Am J Health Syst Pharm. Published online March 25, 2021. doi:10.1093/ajhp/zxab122 Online ahead of print.
Abstract
In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
Document Type
Article
PubMed ID
33764438
DOI
10.1093/ajhp/zxab122
Affiliations
Advocate Medical Group